Chronic pain, by definition, is difficult to manage, but a new study shows how a cell therapy might one day be used not only to quell some common types of persistent and difficult-to-treat pain, but also to cure the conditions that give rise to them.

Transplanting tissue from newborn fetal membranes prevents blindness in patients with a devastating disease called Stevens-Johnson syndrome, a new study has found.

New data shows the gut microbiota's causal role in the development of diabetes and non-alcoholic fatty liver disease, independent of obesity.

Researchers describe details of patient preparation, novel design and execution of the operation as well as unique immunosuppression protocol allowing for lowest long-term maintenance drug regimen.

By combining conventional medical imaging with some of the same 3-D modeling techniques used in Hollywood blockbusters, researchers are offering new hope to victims of serious facial injuries who may be candidates for human facial transplants.

Older patients with advanced hematologic malignancies, such as leukemia and lymphoma, who received a conditioning regimen that included minimal-intensity radiation therapy prior to allogeneic (genetically different) hematopoietic cell transplantation (HCT; receipt of bone marrow or stem cells transplant) had survival and progression-free survival outcomes suggesting that this treatment approach may ...

Age alone no longer should be considered a defining factor when determining whether an older patient with blood cancer is a candidate for stem cell transplantation. That's the conclusion of the first study summarizing long-term outcomes from a series of prospective clinical trials of patients age 60 and over who ...

Researchers have found a way to create melanocytes from mouse tail cells using embryonic stem cell-like intermediates called inducible pluripotent (iPS) cells. They converted mouse tail-tip fibroblasts into iPS cells, producing pluripotent cells similar to embryonic stem cells, but without the concomitant ethical issues.

Researchers have identified eight risk factors for potential re-transplantation failure and, using mathematical modeling, developed a risk scoring system ranging from 0 to 12 to gauge the risk of re-transplantation failure.

New research shows liver transplantation candidates without hepatocellular carcinoma (HCC) derive a greater survival benefit from a living donor liver transplant (LDLT) than waiting for a deceased donor liver transplant (DDLT).

Postoperative outcomes of severe heart failure patients bridged with short-term VADs to urgent (~ status UNOS 1A) heart transplantation are significantly worse than those of patients bridged with conventional support, recent data suggest.

Bone marrow transplantation with genetically modified cells may prolong the period of cancer-free survival, suggests a new study.